Tagrisso (osimertinib) - AstraZeneca
Zykadia (ceritinib) - Novartis
Alecensa (alectinib) - Roche
OBX02-011 - Oncobix
Xalkori (crizotinib) - Pfizer
Lorbrena (lorlatinib) - Pfizer
Alunbrig (brigatinib) - Takeda
https://cattendee.abstractsonline.com/meeting/20598/presentation/2267
 
S. Heo1; S. Lee2; T. Ha2; M. Baek2; M. Kim2; K. Jung2; S-E. Kim2
 
Jul 24, 2024
 
Next